RACHELLE SIMS: Open Payments
NPI 1134769854 · ABILENE, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$246 in 11 payments from 6 companies in 2025. Trend: 2023 $249 · 2024 $216 · 2025 $246
Food & beverage: $246
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 2 | $86 |
| Lilly USA, LLC | 2 | $39 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| Otsuka America Pharmaceutical, Inc. | 2 | $32 |
| Amgen Inc. | 2 | $30 |
| Grifols USA, LLC | 1 | $25 |
Products named: Korlym, MOUNJARO, REXULTI, EVENITY, Prolastin-C Liquid, BEXSERO, SHINGRIX.
Industry payments across KS — which companies pay providers there.
